Agarwal Cost Of Revenue from 2010 to 2025

AGARIND Stock   875.70  0.20  0.02%   
Agarwal IndustrialLimite's Cost Of Revenue is increasing over the years with slightly volatile fluctuation. Overall, Cost Of Revenue is expected to go to about 23.1 B this year. During the period from 2010 to 2025 Agarwal IndustrialLimite Cost Of Revenue annual values regression line had geometric mean of  3,755,182,184 and mean square error of 9367670.2 T. View All Fundamentals
 
Cost Of Revenue  
First Reported
2011-12-31
Previous Quarter
2.1 B
Current Value
4.1 B
Quarterly Volatility
1.9 B
 
Yuan Drop
 
Covid
Check Agarwal IndustrialLimite financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agarwal IndustrialLimite's main balance sheet or income statement drivers, such as Depreciation And Amortization of 363.4 M, Interest Expense of 249.5 M or Total Revenue of 25.7 B, as well as many indicators such as . Agarwal financial statements analysis is a perfect complement when working with Agarwal IndustrialLimite Valuation or Volatility modules.
  
This module can also supplement various Agarwal IndustrialLimite Technical models . Check out the analysis of Agarwal IndustrialLimite Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Agarwal Stock

Agarwal IndustrialLimite financial ratios help investors to determine whether Agarwal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Agarwal with respect to the benefits of owning Agarwal IndustrialLimite security.